I can’t get that Tai-Chi woman out of my head from the initial Celebrex ads way back when–remember those ads? Regardless, if you were buying Celebrex (or Bextra) back then, just a reminder…the deadline to file a claim (or opposition) for the Pfizer Bextra and Celebrex Settlement is October 23, 2009…16 days from now.
The lawsuit claimed that Pfizer marketed Bextra and Celebrex as having more benefit than non-selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like ibuprofen or naproxen (that you can find on drugstore and grocery store shelves), when such benefits had not been established. Additionally, the lawsuit claimed that Pfizer’s marketing of Bextra and Celebrex was inconsistent with their FDA-approved labels, and that these false marketing tactics made consumers pay more for Bextra and Celebrex than they might have been able to pay for OTC NSAIDs, or no medication at all.
The Bextra/Celebrex Settlement is $89 million, and will be paid out in the following manner: 70% to Third-Party Payors, and 30% to consumers.
If you paid for a Bextra or Celebrex prescription on or before July 29, 2005, you may be part of the class and eligible to file a claim.
There are 3 sub-classes in this settlement:
1. All consumers who paid for prescriptions of Bextra, or BOTH Bextra and Celebrex (“Bextra Subclass”)
2. All consumers who paid for prescriptions of Celebrex, but NOT Bextra prior to July 29, 2005 (“Celebrex Subclass”)
3. All Third-Party Payors who reimbursed or paid for Bextra and/or Celebrex (“TPP Subclass”)
Contact the Bextra and Celebrex Claims Administrator by either calling 1-800-547-9360, or visiting their website at bextracelebrexsettlement.com.